viernes, 4 de diciembre de 2015

Genetic mutations: Wolf-Hirschhorn syndrome


Wolf-Hirschhorn syndrome (4p16.3 deletion)


Wolf Hirschhorn syndrome or 4p- is a rare developmental disease characterized by multiple congenital anomalies and mental retardation. An incidence of 1 per estimated 50,000 newborns. It is characterized by a peculiar shaped face Greek helmet, microcephaly, cranial asymmetry, hypertelorism, bilateral coloboma, retrognathia, carp-shaped mouth, dysplastic and low-set ears, seizures with usually 9-10 months early start, congenital heart disease (which is present from birth): aortic coarctation, atrial and ventricular septal defect, incurvado penis, hypospadias, renal hypoplasia or absence in less than 10% of cases and mental retardation.
Physical signs and symptoms

·         Its main features are:
·         Typical childhood craniofacial features consisting of "short Greek warrior helmet appearance of the nose (the bridge of the nose continues on the wide front), microcephaly, high forehead with prominent glabella, ocular hypertelorism, epicanthal folds, highly arched eyebrows, filtrum , mush mouth, micrognathia and malformed ears with pits / tags.
·         All affected individuals have prenatal onset growth deficiency followed by postnatal growth retardation and underdevelopment with muscular hypotonia.
·         The developmental delay or intellectual disability is present to varying degrees in all.
·        Seizures occur between 50% and 100% of children with SWH.
·         Other findings include skeletal abnormalities (60% -70%), congenital heart defects (~ 50%), hearing loss (mostly drivers) (> 40%), urinary tract malformations (25%), and structural brain abnormalities (33%).
·         Low birth weight.
·         Muscle tone at birth.

·         Small head (microcephaly).

·         Skull with asymmetry.

·         Lip and cleft palate (cleft lip) in 50% of patients.

·         Distinctive face; Greek helmet shaped.

·         Jaw rearward.

·         Low-set ears.

·         A set of specific features of the eyes is presented.

·         Lack of tear duct.

 

 
 
 
 
 
 
 
 
 
 

 
Although it is difficult to determine the frequency of this syndrome in newborn infants, has been estimated at between 1 / 50,000 to 1 / 20,000 births, and has been observed in all ethnic groups, most of them in women than men in a ratio of two one.

Medical Complications
·         Seizures: can start early from 9-10 months.
·         Congenital heart diseases: coarctation of the aorta, atrial septal defect, ventricular septal defect.
·         Hypospadias: malformation in which the male urethral opening is not located at the tip of the penis but in its bottom. In 50% of patients.
·         Malformations in the kidneys: incomplete or faulty development or absence of a kidney (less than 10% of cases)
 

Causes
The Wolf-Hirschhorn syndrome is caused by partial deletion of the short arm of chromosome IV, in particular in the region WHSC1 and WHSC2.
About 87% of the cases represent a de novo deletion, while about 13% are inherited from a parent with a chromosomal translocation. The severity of symptoms and the expressed phenotype vary depending on the amount of genetic material has been removed. The critical region for determining the phenotype is in 4p16.3 and often can be detected by genetic and fluorescence in situ hybridization tests. It should always be offered genetic counseling to affected families with Wolf-Hirschhorn syndrome.
 

Cytogenetic diagnosis
The clinical diagnosis is not certain, but a suspicion that requires confirmation with the definite diagnosis obtained from cytogenetic analysis and / or molecular. By high resolution chromosome study (500-850 bands) the deletion was detected only in 70% of cases with clinical diagnosis. This is because the loss of the end of the short arm of chromosome 4 may be very small, and techniques need whose resolution is higher. At present, the most used is the fluorescence in situ hybridization (FISH), with which the deletion is detected in up to 95% of patients with clinically suspected.
Treatment
So far there is no treatment for this disease. Treatment is directed to reduce medical complications that arise in each particular case. The prognosis is grave, about a third of patients die before two years of age, cardiological bronco pulmonary complications, and few cases have been described with 10-16 years than survival. Survivors have severe mental retardation and growth retardation prone to recurrent infections bronchopulmonary. It is associated with a deletion in the short arm of chromosome 4 (4p16.3). Most cases are 85-90% novo deletions.















Bibliography:

  • Alexandra M.D.; Isabella.; Maria Luisa M.F .; Maria D. S .; and Maria Luisa M.F .. (April 2010). Wolf-Hirschhorn syndrome. A S E R E M E C E M AC C, 20, 1-2.
  •  Article: Wolf-Hirschhorn syndrome. May 28, 2011. Available at: "yasalud.com". Accessed: February 23, 2012.
  •  Dr. Iacobini, Sandra.; Dra. Lotersztein, Vanessa and equipment. Medical News: "Rare diseases" or "orphan". Available in: "www.intramed.net". Cosnultado: February 23, 2012.
  •  Aviña orge A. F .; Daniel A. Hernández A. Wolf-Hirschhorn Syndrome: distal microdeletion short arm of chromosome 4. 3 November 2007. Available at: "www.scielo.cl". Cosnultado: February 23, 2012.

1 comentario:

  1. Irrespective of receiving daily oral or future injectable depot therapies, these require health care visits for medication and monitoring of safety and response. If patients are treated early enough, before a lot of immune system damage has occurred, life expectancy is close to normal, as long as they remain on successful treatment. However, when patients stop therapy, virus rebounds to high levels in most patients, sometimes associated with severe illness because i have gone through this and even an increased risk of death. The aim of “cure”is ongoing but i still do believe my government made millions of ARV drugs instead of finding a cure. for ongoing therapy and monitoring. ARV alone cannot cure HIV as among the cells that are infected are very long-living CD4 memory cells and possibly other cells that act as long-term reservoirs. HIV can hide in these cells without being detected by the body’s immune system. Therefore even when ART completely blocks subsequent rounds of infection of cells, reservoirs that have been infected before therapy initiation persist and from these reservoirs HIV rebounds if therapy is stopped. “Cure” could either mean an eradication cure, which means to completely rid the body of reservoir virus or a functional HIV cure, where HIV may remain in reservoir cells but rebound to high levels is prevented after therapy interruption.Dr Itua Herbal Medicine makes me believes there is a hope for people suffering from,Parkinson's disease,Schizophrenia,Lung Cancer,Breast Cancer,psoriasis,Colo-Rectal Cancer,Blood Cancer,Prostate Cancer,siva.Fatal Familial Insomnia Factor V Leiden Mutation ,Epilepsy Dupuytren's disease,Desmoplastic small-round-cell tumor Diabetes ,Coeliac disease,Creutzfeldt–Jakob disease,Cerebral Amyloid Angiopathy, Ataxia,Arthritis,Amyotrophic Lateral Scoliosis,Fibromyalgia,Fluoroquinolone Toxicity
    Syndrome Fibrodysplasia Ossificans ProgresSclerosis,Alzheimer's disease,Adrenocortical carcinoma.Asthma,Allergic diseases.Hiv_ Aids,Herpe ,Copd,Glaucoma., Cataracts,Macular degeneration,Cardiovascular disease,Lung disease.Enlarged prostate,Osteoporosis.Alzheimer's disease,
    Dementia.(measles, tetanus, whooping cough, tuberculosis, polio and diphtheria),Chronic Diarrhea,
    Hpv,All Cancer Types,Diabetes,Hepatitis,I read about him online how he cure Tasha and Tara so i contacted him on drituaherbalcenter@gmail.com / info@drituaherbalcenter.com. even talked on whatsapps +2348149277967 believe me it was easy i drank his herbal medicine for two weeks and i was cured just like that isn't Dr Itua a wonder man? Yes he is! I thank him so much so i will advise if you are suffering from one of those diseases Pls do contact him he's a nice man.

    ResponderBorrar